Oncology Peer Review On-The-Go: Current Treatments in Peripheral T-cell Lymphoma
Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, spoke with CancerNetwork® about a review article on the treatment of peripheral T-cell lymphoma published in the journal ONCOLOGY®.
Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, both of the Lymphoma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, spoke with CancerNetwork® about their review published in the journal ONCOLOGY® titled Current Treatment of Peripheral T-cell Lymphoma.
In the article, Stuver and Epstein-Peterson explored current approaches to the diagnosis and treatment of peripheral T-cell lymphoma and novel emerging strategies clinicians who are practicing in the community should be aware of.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.
Rare Primary ALK-Positive Anaplastic Large Cell Lymphoma of the Central Nervous System
Anaplastic large cell lymphoma is a rapidly growing and aggressive hematological malignancy. This case highlights the rarity of isolated intradural extramedullary manifestations in the pediatric population.
